Skip to main content

Table 2 Factors associated with in-hospital mortality among patients with acute kidney injury or end-stage renal disease

From: Continuous renal replacement therapy outcomes in acute kidney injury and end-stage renal disease: a cohort study

 

Odds ratio

95% CI

P-value

A: Acute kidney injury

   

Age >60 years

1.6

1.2, 2.2

0.002

Female

0.96

0.71, 1.3

0.82

White race

0.87

0.60, 1.2

0.43

Medical ICU

1.2

0.9, 1.6

0.19

Lactate >4 mmol/L

2.4

1.7, 3.3

<0.001

Albumin >3 g/dL

0.83

0.61, 1.1

0.26

BUN > 30 mg/dL (at admission)

1.1

0.81, 1.5

0.54

Creatinine >2 mg/dL (at admission)

0.76

0.56, 1.0

0.08

BUN >50 mg/dL (at CRRT initiation)

1.3

0.94, 1.7

0.12

Creatinine >3 mg/dL (at CRRT initiation)

0.56

0.41, 0.77

<0.001

Charlson score >3

1.6

1.1, 2.3

0.006

Liver disease

1.8

1.2, 2.8

0.005

B: ESRD

   

Age >60 years

0.88

0.45, 1.7

0.72

Female

1.2

0.60, 2.5

0.57

White race

0.60

0.25, 1.4

0.24

Medical ICU

2.4

1.1, 4.9

0.02

Lactate >4 mmol/L

1.5

0.28, 7.6

0.65

Albumin >3 g/dL

0.79

0.24, 2.6

0.70

Charlson score >3

2.4

1.0, 5.7

0.05

Liver disease

3.7

1.2, 11.8

0.03

  1. (A) Acute kidney injury (AKI) (n = 725). (B) End-stage renal disease (ESRD) (n = 138). BUN, blood urea nitrogen; CRRT, continuous renal replacement therapy.